Sodium 2-fluoro-α-methyl[1,1'-biphenyl]-4-acetate

CAS : 56767-76-1

Ref. 3D-FS93388

Informations sur le produit

• Nom: Sodium 2-fluoro-α-methyl[1,1'-biphenyl]-4-acetate
• Synonymes: Flurbiprofen sodium, 2-(2-Fluorobiphenyl-4-yl)propionic acid sodium salt, 2-Fluoro-α-methyl-4-diphenylacetic acid sodium salt, 2-fluoro-α-methyl-[1,1'-Biphenyl]-4-acetic acid sodium salt, Flurbiprofen Sodium, Flurbiprofen sodium salt, Ocufen, Ocuflur, Sodium 2-(2-Fluorobiphenyl-4-Yl)Propanoate, Sodium 3-fluoro-4-phenyl hydratropate, Sodium 3-fluoro-4-phenylhydratropate, Sodium flurbiprofen, [1,1′-Biphenyl]-4-acetic acid, 2-fluoro-α-methyl-, sodium salt, [1,1′-Biphenyl]-4-acetic acid, 2-fluoro-α-methyl-, sodium salt (1:1)

Description

Sodium 2-fluoro-alpha-methyl[1,1'-biphenyl]-4-acetate is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits the activity of enzymes involved in inflammatory reactions. It has shown to be an effective treatment for the reduction of pain and inflammation associated with certain diseases, including rheumatoid arthritis. The drug also binds to DNA and blocks its ability to form supercoiled strands. This binding prevents transcription of genetic information from DNA into RNA, which is needed for protein production. Sodium 2-fluoro-alpha-methyl[1,1'-biphenyl]-4-acetate has been shown to inhibit bcl2 protein expression and may increase the risk of developing cancer. The drug can cause adverse effects such as headache and stomach upset when taken at high doses.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 266.24 g/mol
• Formule: C₁₅H₁₃FO₂•Na
• Degré de pureté: Min. 95%